Isotope-Labeled Compounds
Isotope-labeled compounds are chemical substances in which some atoms in their molecules are replaced by isotope atoms. The range of stable isotope products can cover from gases to complex molecules. Isotope-labeled compounds could provide a site-specific investigation of structures, making molecules easily detectable by mass spectrometry and NMR, and maintaining the physico-chemical properties of the target molecule at the same time.
MCE isotope-labeled compounds are all stable isotope-labeled compounds and are non-radioactive labeled substances. MCE isotope-labeled compounds are unique tools for identifying and understanding biological and chemical processes. Stable isotope-labeled products are now getting more and more popular among scientists. The scope of application is gradually penetrating into various scientific fields, such as life sciences, food and medicine, agriculture, environment, geology, etc. Stable isotope-labeled compounds have a wide range of applications in the Life Science areas, such as Metabolomics, Proteomics, Clinical studies, Deuterium drugs, etc.
All Product Categories
-
Isotope-Labeled Compounds Related Products (11128)
Related Products (11128)
-
Agmatine-d8 sulfate
0 ImagesCat. No.: HY-101238SCAS No.: 909556-32-7Agmatine-d8 sulfate is a deuterium labeled Agmatine sulfate (HY-101238). Agmatine sulfate exerts modulatory action at multiple molecular targets, such as neurotransmitter systems, ion channels and nitric oxide synthesis. It is an endogenous agonist at imidazoline receptor and a NO synthase inhibitor.
-
N-Acetyl-L-glutamic acid-d4
0 ImagesCat. No.: HY-W015240S1N-Acetyl-L-glutamic acid-d4 is the deuterium labeled N-Acetyl-L-glutamic acid (HY-W015240). N-Acetyl-L-glutamic acid is a type of glutamic acid that can serve as a component of cell culture media. When combined with media containing inorganic salts, carbohydrates, vitamins, and amino acids, N-Acetyl-L-glutamic acid plays roles in promoting cell growth, enhancing antibody production, etc. N-Acetyl-L-glutamic acid is also an endogenous metabolite that can be found in the brain. Additionally, as an IgE blocker, N-Acetyl-L-glutamic acid can be used in the research of allergic diseases.
-
N-Desbutyl bupivacaine-d6
0 ImagesCat. No.: HY-W045132SSynonyms: Desbutylbupivacaine-d6N-Desbutyl bupivacaine-d6 (Desbutylbupivacaine-d6) is the deuterium labeled N-Desbutyl Bupivacaine (HY-W045132). N-Desbutyl Bupivacaine (compound 100) is a metabolite of Bupivacaine (HY-B0405), an NMDA receptor inhibitor and SCN5A antagonist.
-
4-Ethylpicolinic acid-d5 hydrochloride
0 ImagesCat. No.: HY-W702215CAS No.: 1329836-38-54-Ethylpicolinic acid-d5 hydrochloride is the deuterium labeled 4-Ethylpicolinic acid hydrochloride (HY-W024941).
-
Levomedetomidine-d8
0 ImagesCat. No.: HY-135735S1Levomedetomidine-d8 is the deuterium labeled Levomedetomidine.
-
Ciclesonide-d11 (Mixture of Diastereomers)
0 ImagesCat. No.: HY-W766409Ciclesonide-d11 (Mixture of Diastereomers) is the deuterium labeled Ciclesonide.
-
Fmoc-Phe-OH-13C6
0 ImagesCat. No.: HY-79131SCAS No.: 446276-60-4Fmoc-Phe-OH-13C6 is a 13C-labeled Fmoc-Phe-OH (HY-79131). Fmoc-Phe-OH is a phenylalanine derivative.
-
Fomepizole-d2
0 ImagesCat. No.: HY-W724345Synonyms: 4-Methylpyrazole-d2Fomepizole-d2 (4-Methylpyrazole-d2) is the deuterium labeled Fomepizole (HY-B0876). Fomepizole (4-Methylpyrazole) is a potent cytochrome P450 (CYP2E1) inhibitor. Fomepizole is a competitive inhibitor of the enzyme alcohol dehydrogenase. Fomepizole blocks further conversion of methanol and ethylene glycol to toxic metabolites. Fomepizole has the potential for an antidote for ethylene glycol or methanol poisoning.
-
N-(tert-Butoxycarbonyl)aniline-13C6
0 ImagesCat. No.: HY-W778065CAS No.: 176850-21-8N-(tert-Butoxycarbonyl)aniline-13C6 is the 13C-labeled tert-Butyl phenylcarbamate (HY-W009968).
-
Undecylamine-d23
0 ImagesCat. No.: HY-W110698SCAS No.: 1219805-57-8Undecylamine-d23 is the deuterium labeled Undecylamine.
-
5,8-Dihydroindolo[2,3-c]carbazole-d10
![5,8-Dihydroindolo[2,3-c]carbazole-d10](https://file.medchemexpress.com/product_pic/hy-w587223s.gif "Click to View 5,8-Dihydroindolo[2,3-c]carbazole-d10 Product Detail")
0 ImagesCat. No.: HY-W587223SCAS No.: 2829268-34-85,8-Dihydroindolo[2,3-c]carbazole-d10 is the deuterium labeled 5,8-Dihydroindolo[2,3-c]carbazole.
-
Clopidogrel-MP endo derivative-13C,d3
0 ImagesCat. No.: HY-Z2483SCAS No.: 1346597-76-9Clopidogrel-MP endo derivative-13C,d3 is the deuterium and 13C labeled Clopidogrel-MP endo derivative.
-
Diltiazem-d5 hydrochloride
0 ImagesCat. No.: HY-14656S3CAS No.: 2012598-70-6Synonyms: CRD-401-d5Diltiazem-d5 (CRD-401-d5) hydrochloride is deuterium-labeled Diltiazem (hydrochloride) (HY-14656).
-
1-Phenylpentane-d5
0 ImagesCat. No.: HY-W087024SCAS No.: 68639-73-6Synonyms: Pentylbenzene-d51-Phenylpentane-d5 is the deuterium labeled 1-Phenylpentane.
-
D-Lactosyl-β-1,1'-N-pentadecanoyl-D-erythro-sphingosine-d7
0 ImagesCat. No.: HY-146764SCAS No.: 2315262-20-3D-Lactosyl-β-1,1'-N-pentadecanoyl-D-erythro-sphingosine-d7 is deuterium labeled D-Lactosyl-β-1,1'-N-pentadecanoyl-D-erythro-sphingosine.
-
Ethyl 2-ethyl-3-oxobutanoate-d5
0 ImagesCat. No.: HY-W700518CAS No.: 141327-44-8Synonyms: Ethyl 2-ethylacetoacetate-d5Ethyl 2-ethyl-3-oxobutanoate-d5 (Ethyl 2-ethylacetoacetate-d5) is the deuterium labeled Ethyl 2-ethyl-3-oxobutanoate (HY-W008164).
-
Ospemifene-d4
0 ImagesCat. No.: HY-B0723SPurity: 99.65%Synonyms: FC-1271a-d4Ospemifene-d4 is a deuterium labeled Ospemifene. Ospemifene is a selective and orally active estrogen receptor modulator for the prevention of osteoporosis with IC50 values of 827 nM and 1633 nM for estrogen receptor α (ERα) and ERβ, respectively. Ospemifene has bone-sparing, antitumor, and cholesterol-lowering effects.
-
4-Hydroxy biphenyl sulfate-d5 sodium
0 ImagesCat. No.: HY-143928S4-Hydroxy biphenyl sulfate-d5 (sodium) is the deuterium labeled 4-Hydroxy biphenyl sulfate.
-
Nortriptyline impurity 3-d3 hydrochloride
0 ImagesCat. No.: HY-144141SNortriptyline impurity 3-d3 (hydrochloride) is the deuterium labeled Nortriptyline impurity 3 hydrochloride.
